Clinical Evaluation of Fractional Bi-Polar Radio-Frequency for Symptoms of Stress Urinary Incontinence and Vulvovaginal Atrophy
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
An objective change as measured by standardized cough stress test
Timeframe: Day 0, Month 6
An objective evaluation of vaginal atrophy/estrogenization
Timeframe: Day 0, month 6
The effect of the treatment on urinary symptoms and quality of life by means of the Incontinence Quality of Life (IQOL) Questionnaire
Timeframe: Day 0, month 6
The effect of the treatment on urinary symptoms by means of Urogenital Distress Inventory 6 Questionnaire
Timeframe: day 0, month 6
The effect of the treatment on urinary symptoms by means of Bladder voiding diary after the treatment
Timeframe: Day 0, month 6
The effect of the treatment on urinary symptoms by means of Medical, Epidemiologic, and Social Aspects of Aging Urinary Incontinence (MESA) Questionnaire
Timeframe: Day 0, month 6
Evaluation of histological changes to vaginal canal tissue
Timeframe: Day 0, month 3